Vaginal Tightening in Gangnam, Seoul — Viveve, MonaLisa Touch, AMOS

Many patients searching for vaginal tightening in Seoul compare clinics by device brand. Device names matter less than two things: whether the clinic can offer more than one energy modality (so the choice fits your condition rather than the clinic's only machine), and whether a board-certified OB-GYN examines you first. This page explains the devices in clinical use at Lydia Women's Clinic, what published research does and does not show, and practical information for visitors to Gangnam.

Devices in clinical use at Lydia Women's Clinic

• Viveve — cryogen-cooled monopolar RF. Cools the mucosal surface while heating deeper tissue, targeting submucosal collagen. Considered mainly for laxity-type concerns, often after childbirth.
• AMOS — temperature-controlled RF. A thermal sensor monitors probe-surface temperature in real time. Its treatment range extends beyond the vaginal canal to the vulvar area (labia), making it an option when external laxity is a concern as well.
• MonaLisa Touch — fractional CO₂ laser. Delivers micro-dot laser pulses that stimulate regeneration of thinned mucosa. Considered mainly for dryness and atrophy-type symptoms, including after menopause or cancer treatment.
• Er:YAG laser (2,940nm). Energy concentrates in the superficial layer with a narrower thermal zone, generally associated with shorter downtime.

A session typically takes 20–30 minutes; most patients return to daily activities the same day, with intercourse and strenuous exercise restricted for a period advised at the visit.

What the evidence shows — and its limits

For radiofrequency, a 12-month prospective study of dynamic quadripolar RF reported efficacy and safety for vaginal laxity and menopausal vulvo-vaginal atrophy (Minerva Ginecologica, 2017). For fractional CO₂ laser, a two-year follow-up study reported effectiveness for vaginal laxity with retreatment-need data (Lasers in Medical Science, 2026), and a systematic review with meta-analysis of vaginal laxity treatments reported symptom improvement across energy-based modalities (Journal of Sexual Medicine, 2024).

Balance matters: the U.S. FDA's 2018 safety communication cautioned against marketing energy-based devices for "vaginal rejuvenation" claims beyond their cleared indications (FDA, 2018). Study protocols and endpoints vary, evidence is still accumulating, and individual results differ. A trustworthy consultation names the device, its cleared indication, and the realistic range of outcomes — and screens for conditions (active inflammation, pregnancy, cervical abnormality) that rule the procedure out.

Who is — and is not — a candidate

• Considered for: mild-to-moderate laxity after childbirth; dryness or discomfort associated with genitourinary syndrome of menopause (GSM); patients preferring a non-surgical option with gradual improvement.
• Not suitable during: pregnancy, active vaginal or pelvic inflammation, or unevaluated cervical abnormality — an examination precedes any scheduling.
• Different goal, different tool: if the goal is immediate volume augmentation rather than tissue remodeling, hyaluronic-acid filler is a separate option discussed at consultation; surgical vaginoplasty is a different pathway for advanced laxity.

Visiting from abroad — location and practical notes

Lydia Women's Clinic is at 9F Jump Milano, 432 Gangnam-daero, Gangnam-gu, Seoul — about 250m from Sinnonhyeon Station (Line 9, Exit 6) and a short walk from Gangnam Station, in central Gangnam. The clinic is directed by Dr. Seungho Hong, a board-certified OB-GYN specialist (adjunct professor of OB-GYN at Dongguk University Hospital; member of the Korean Society of Urogynecology). Consultations are conducted in Korean; international visitors who need language support are advised to arrange an interpreter or a medical-tourism concierge service in advance. Phone: +82-2-3482-2300.

FAQ

Korean-language details: 질타이트닝 시술 안내 (한국어) · 장비 비교 가이드 (한국어)